UNC LINEBERGER COMPREHENSIVE CANCER CENTER IMAGE: UNC LINEBERGER’S WILLIAM KIM, MD, AND COLLEAGUES REPORT THEIR RESEARCH DEMONSTRATED THAT PATIENTS WITH ADVANCED BLADDER CANCERS WHOSE TUMORS HAVE A MUTATED FGFR3 GENE RESPOND TO IMMUNOTHERAPY IN A MANNER THAT IS SIMILAR TO PATIENTS WITHOUT THAT MUTATION. THIS DISCOVERY RUNS COUNTER TO PREVIOUS RESEARCH THAT SUGGESTED FGFR3-MUTATED BLADDER...
